About Galvanize
Therapeutics®

Galvanize is a biomedical platform company operating at the convergence of engineering, biology, and healthcare delivery, aiming to deliver life-changing solutions to patients and their doctors.

We create Pulsed Electric Field technologies capable of targeting cells involved in disease processes, in ways unparalleled to other devices or drugs.

We study our technologies in well designed clinical trials to ensure safety and efficacy.

We partner with doctors and healthcare systems so that patients can access our therapies.

Learn more about the Galvanize science and technology platform

Galvanize Leadership

Jonathan Waldstreicher, MD
Founder and Chief Executive Officer
BIO
Kevin Taylor
Chief Operating Officer
BIO
Bill Krimsky, MD
Chief Medical Officer
BIO
Name TK
Chief Financial Officer
BIO
Jonathan Waldstreicher, MD
Founder and
Chief Executive Officer
Kevin Taylor
Chief Operating Officer
Deb Sheffield

Chief Regulatory Officer

Steve Anheier
Chief Financial Officer
William S. Krimksy, MD, FCCP, DAABIP

Chief Medical Officer

Bill Green

Senior Vice President, Sales and Marketing

Board of Directors

Doug Godshall, CHAIR
President and CEO, Shockwave Medical
Anna Batarina, CFA
Partner, ATP
Seth Harrison, MD
Founder and Managing Partner, ATP
Jonathan Waldstreicher, MD

Founder and CEO,
Galvanize Therapeutics

Mohit Trikha, PhD
Venture Partner, ATP

Investors

Galvanize Therapeutics was created and incubated by ATP (Apple Tree Partners).

Other investors in Galvanize Therapeutics include Intuitive Surgical, Gilmartin Capital, and T. Rowe Price.